CPC
LEGN icon

Cookson Peirce & Co’s Legend Biotech LEGN Stock Holding History

Cookson Peirce & Co’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$866K Buy
+30,000
New +$809K 0.03% 218

Other funds holding LEGN

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
EFMH
E Fund Management (HK) Central, Hong Kong $302M AUM 64.42% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
TPSF
Texas Permanent School Fund Austin, Texas $2.26B AUM 7.02% 1-Year Est. Return
YMRC
Yorktown Management & Research Company Forest, Virginia $163M AUM 68.53% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
AWM
Avior Wealth Management Omaha, Nebraska $3.8B AUM 23.28% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Cookson Peirce & Co's LEGN Position: Q2 2026 in Review

Cookson Peirce & Co opened a new position in Legend Biotech (LEGN) in Q2 2026: 30,000 shares worth $866K. The stake represents 0.03% of the portfolio and ranks #218 among its holdings.

27 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Cookson Peirce & Co held 30,000 shares of Legend Biotech worth $866K as of Q2 2026.
  • Legend Biotech was a new Cookson Peirce & Co position in Q2 2026.
  • Legend Biotech made up 0.03% of Cookson Peirce & Co's portfolio in Q2 2026, its #218 holding.
  • 27 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Cookson Peirce & Co's 13F filing for Q2 2026, filed 23 Jul 2026.